The treatment of severe malaria.
In the SEAQUAMAT trial, parenteral artesunate was shown to be associated with a considerably lower mortality than quinine, and is now the recommended treatment for severe malaria in low-transmission areas and in the second and third trimesters of pregnancy. A trial is underway to establish its role...
Autori principali: | Dondorp, A, Day, N |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
2007
|
Documenti analoghi
-
The management of patients with severe malaria.
di: Day, N, et al.
Pubblicazione: (2007) -
The treatment of severe malaria
di: Dondorp, A
Pubblicazione: (2007) -
UK recommendations for severe malaria are worrying.
di: White, N, et al.
Pubblicazione: (2007) -
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
di: Dondorp, A, et al.
Pubblicazione: (2005) -
Malaria treatment in the United States.
di: Hanson, J, et al.
Pubblicazione: (2007)